Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115636236 | 11563623 | 6 | F | 20160923 | 20150928 | 20160927 | EXP | US-PFIZER INC-2015321214 | PFIZER | 6.00 | YR | F | Y | 18.00000 | KG | 20160927 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115636236 | 11563623 | 1 | PS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 0.8 MG, DAILY | 20280 | .8 | MG | POWDER FOR SOLUTION FOR INJECTION | |||||||
| 115636236 | 11563623 | 2 | SS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 0.7 MG, DAILY | 20280 | .7 | MG | POWDER FOR SOLUTION FOR INJECTION | |||||||
| 115636236 | 11563623 | 3 | SS | GENOTROPIN | SOMATROPIN | 1 | 20280 | POWDER FOR SOLUTION FOR INJECTION | |||||||||||
| 115636236 | 11563623 | 4 | SS | NORDITROPIN | SOMATROPIN | 1 | Subcutaneous | UNK | U | 0 | |||||||||
| 115636236 | 11563623 | 5 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115636236 | 11563623 | 1 | Growth hormone deficiency |
| 115636236 | 11563623 | 2 | Dwarfism |
| 115636236 | 11563623 | 3 | Growth hormone deficiency |
| 115636236 | 11563623 | 4 | Growth hormone deficiency |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115636236 | 11563623 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115636236 | 11563623 | Injection site discomfort | |
| 115636236 | 11563623 | Injection site injury | |
| 115636236 | 11563623 | Injection site pain | |
| 115636236 | 11563623 | Melanocytic naevus | |
| 115636236 | 11563623 | Pharyngitis streptococcal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115636236 | 11563623 | 1 | 201410 | 0 | ||
| 115636236 | 11563623 | 2 | 20150114 | 0 | ||
| 115636236 | 11563623 | 5 | 201601 | 0 |